MP Healthcare Venture Management Inc Overview

Company Details

Founded in 2006, is a subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC). The firm invests in seed to late-stage life sciences ventures based principally in North America and Europe. MPH focuses on medical diagnostics, biotechnology, vaccines and therapeutics. Specific areas of interest include: Cardiology, Stroke, Metabolic disease, Nephrology, Immunology and Inflammation, and Neuroscience.

Notable investments include: Covagen (acquired by Cilag), f-star Biotech (acquired by Bristol-Myers Squibb), Genocea Biosciences (NASDAQ: GNCA), Intradigm Corporation (acquired by Silence Therapeutics),PharmEste S.r.l. and Pronota NV.

Locations

Location
617-737-4695,
33 Arch Street, 02110 MA
United States

WSO Company Database Comparison Table

Get Full Access

  • Free 1 month access by adding just 1 salary datapoint here
  • REAL salary bonus data across 1,000+ companies
  • Plus free 1 month access to 10,000+ interview insights

Unlock WSO Database

1 month free. Add your own pay data.